Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphopenia × efineptakin alfa × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Sarcoma, Kaposi 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Lymphopenia 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Locally Advanced or Metastatic Solid Tumors 1 HIV Infections 1 Glioma 1 Colorectal Neoplasms 1 Breast Neoplasms 1 AIDS-related Kaposi sarcoma 1

Interventions

efineptakin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02659800 2023-10-06

Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Terminated

Glioma, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡